While Express Scripts (ESRX), the largest pharmacy benefit manager in the country, has a firm grip on its industry, investors have been more concerned with getting a grip on the company's prospects for the future, especially after a negative outlook sent shares south late last year. In the following video, Motley Fool health care bureau chief quickly runs through his assessment of Express Scripts' guidance and discusses a few tailwinds and headwinds facing the company in the near future.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.